Not a small frog in a big pond: targeting bradykinin receptor B2 signaling in vascular smooth muscle cells for treatment of hypertension
- PMID: 37507534
- DOI: 10.1038/s41440-023-01385-w
Not a small frog in a big pond: targeting bradykinin receptor B2 signaling in vascular smooth muscle cells for treatment of hypertension
Keywords: Bradykinin; Calcium signaling; Hypertension; Pharmacology; Vascular smooth muscle.
Comment on
-
Maximakinin reduced intracellular Ca2+ level in vascular smooth muscle cells through AMPK/ERK1/2 signaling pathways.Hypertens Res. 2023 Aug;46(8):1949-1960. doi: 10.1038/s41440-023-01330-x. Epub 2023 Jun 1. Hypertens Res. 2023. PMID: 37258626
References
-
- Prados MD, Schold SC Jr, Fine HA, Jaeckle K, Hochberg F, Mechtler L, et al. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. Neuro Oncol. 2003;5:96–103. - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources